MedPath

Linolenic acid

Generic Name
Linolenic acid
Drug Type
Small Molecule
Chemical Formula
C18H30O2
CAS Number
463-40-1
Unique Ingredient Identifier
0RBV727H71

Overview

Alpha-linolenic acid (ALA) is a polyunsaturated omega-3 fatty acid. It is a component of many common vegetable oils and is important to human nutrition.

Indication

For nutritional supplementation and for treating dietary shortage or imbalance.

Associated Conditions

No associated conditions information available.

Research Report

Published: May 1, 2025

Alpha-Linolenic Acid (DB00132): A Comprehensive Scientific Review

I. Introduction to Alpha-Linolenic Acid (ALA)

Alpha-linolenic acid (ALA) is an 18-carbon polyunsaturated fatty acid (PUFA) belonging to the omega-3 (n-3) family.[1] It holds the distinction of being an essential fatty acid (EFA) for humans and other mammals, meaning it is indispensable for normal physiological function but cannot be synthesized de novo within the body.[3] Consequently, ALA must be obtained entirely from dietary sources. This inherent biological limitation underscores ALA's critical nutritional status and necessitates its inclusion in dietary recommendations to prevent deficiency and support overall health.

ALA serves as the parent compound for the entire omega-3 fatty acid series. While it can be metabolically converted into longer-chain, more unsaturated omega-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), this conversion process is notably limited in humans.[2] Nevertheless, ALA itself, along with its metabolites, plays significant roles in human nutrition and physiology.[1] It is a structural component of cell membranes and is involved in various signaling pathways.

Found predominantly in plant-based foods, ALA is abundant in certain vegetable oils (flaxseed, canola, soybean), nuts (walnuts), and seeds (flax, chia, hemp).[1] Its presence in common dietary components makes it the most prevalent omega-3 fatty acid in many Western diets.[17] Chemically, ALA is identified by the Chemical Abstracts Service (CAS) number 463-40-1 and the DrugBank identifier DB00132.[1] Its molecular formula is C18​H30​O2​.[1] This report provides a comprehensive overview of the chemical properties, metabolism, dietary sources, physiological functions, health effects, safety considerations, and dietary recommendations pertaining to alpha-linolenic acid.

II. Chemical Properties and Structure

Continue reading the full research report

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2021/08/25
Phase 2
Recruiting
2020/01/09
Phase 4
Completed
Merete Haedersdal
2019/08/05
Phase 1
Completed
2019/07/15
Phase 1
Completed
2018/08/22
Phase 4
Recruiting
Shanghai Dermatology Hospital
2017/02/28
Not Applicable
Active, not recruiting
2017/01/18
Phase 3
Withdrawn
2016/06/14
Phase 2
Completed
2016/06/14
Phase 3
Completed
2016/06/14
Phase 3
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
FLAXSEED OIL CAPSULES
general nutrition canada inc.
02185792
Capsule - Oral
594 MG
5/27/1998
HUILE D'ONAGRE VITAMIN E
le naturiste j.m.b. inc.
00658332
Capsule - Oral
11 %
12/31/1987
BIO-EFA BORAGE GLA 90 CAP
pge canada (86) inc.
00756385
Capsule - Oral
1 MG / CAP
12/31/1989

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.